Buddy Relationships in DermatoloGic Excisions for Skin Cancer
NCT04036344 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2020-03-04
Summary
More than 5 million skin cancer surgeries are performed each year in the United States with 80% of tumors appearing on the head and neck. Facial skin cancer diagnosis negatively affects patient quality of life (QOL) and treatment of skin cancer creates visible scars early in the postoperative period, increases anxiety, and impairs social interactions. We believe that these negative psychosocial changes represent an unmet need for additional social support and practical guidance. A one-to-one peer support program designed for skin cancer patients could provide a focused, cost-effective, patient-centered intervention to improve quality of life and increase satisfaction. Comparable one-to-one peer support programs have demonstrated high rates of patient satisfaction and positive QOL outcomes in a wide range of conditions. This prospective peer support program would be the first of its kind for melanoma and keratinocytic skin cancers. Our pilot program was designed in consultation with leading peer mentorship program researchers and we will implement a structured system to match volunteer mentors with patients. Through qualitative and quantitative data, we will evaluate the program's effect on patient QOL at 3 separate intervals: at initial consultation, 1-2 weeks post-surgery, and 3 months post-surgery. We hope that this study will enable us to design and execute a larger multi-center clinical trial in order to establish a best practice for surgeons to usher patients through the postoperative healing process after skin cancer surgery.
Conditions
- Skin Cancer Face
- Quality of Life
- Surgical Wound
- Peer Mentorship
Interventions
- BEHAVIORAL
-
Peer Mentorship Program
Mentee participants are paired with a previous MMS patient (Mentor) who is greater than 1 year status post MMS treatment for a facial skin cancer. Mentors and mentees maintain regular contact by telephone, video chat, or in-person meetings throughout the mentee's facial skin cancer treatment with MMS.
Sponsors & Collaborators
-
Abramson Cancer Center at Penn Medicine
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-10-12
- Primary Completion
- 2019-08-27
- Completion
- 2019-08-27
Countries
- United States
Study Locations
More Related Trials
-
A Comparison of Interventions to Teach Melanoma Patients Skin Self-examination
NCT01432860 ·Status: COMPLETED ·Phase: NA
-
Study in Patients With Solid Tumor Regarding Access to Dermo-cosmetics and Aesthetic Solutions
NCT05907551 ·Status: UNKNOWN
-
A Study of Neoadjuvant Therapy With BCD-217 (Nurulimab + Prolgolimab) in Patients With Resectable Stage III Skin Melanoma
NCT05751928 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Young Melanoma Family Facebook Intervention or Healthy Lifestyle Facebook Intervention in Improving Skin Examination in Participants With Melanoma and Their Families
NCT03677739 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Skin Care Behaviors Among Melanoma Survivors and Their Families
NCT02457065 ·Status: COMPLETED ·Phase: NA
-
Patient Reported Outcome Measures After Treatment of Skin Cancers on the Face
NCT04485442 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
NCT03969004 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Mentored Community Gardening for Individuals With Skin Cancer
NCT05648604 ·Status: COMPLETED ·Phase: NA
-
A Study To See Why Patients Agree To or Decline To Have Treatment After Surgery
NCT03843593 ·Status: COMPLETED
-
Comparison of Two Strategies for Counseling Skin Examination and Sun Protection in First-degree Relatives of Patients With Melanoma
NCT02917473 ·Status: COMPLETED ·Phase: NA
-
Clinical Study of the Efficacy and Safety of BCD-263 and Opdivo® as Monotherapy in Subjects With Advanced Melanoma of the Skin
NCT06640530 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Testing the Addition of an Immunotherapy Drug, Cemiplimab (REGN2810), Plus Surgery to the Usual Surgery Alone for Treating Advanced Skin Cancer
NCT06568172 ·Status: SUSPENDED ·Phase: PHASE3
-
Bevacizumab Plus Ipilimumab in Patients With Unresectable Stage III or IV Melanoma
NCT00790010 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Elective Lymph Node Treatment Versus Clinical Observation in the Absence of Palpable Lymph Nodes for High Risk Skin Squamous Cell Carcinoma (SCC)
NCT01252329 ·Status: TERMINATED ·Phase: NA
-
Improving Sun-Protective Behaviors and Skin Self-Examinations Among African Americans
NCT02417948 ·Status: COMPLETED ·Phase: NA
-
Melanoma Risk Assessment & Tailored Intervention
NCT01356771 ·Status: COMPLETED ·Phase: NA
-
Optimizing Access to Care Through New Technologies: a Randomized Study Evaluating the Impact of Telephone Contact and the Sending by the General Practitioner of Suspicious Lesions Melanoma Photographs Taken With a Smartphone, on the Time Limit to the Consultation With a Dermatologist
NCT03137511 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Combination Immunotherapy for Stage III Melanoma
NCT03842943 ·Status: RECRUITING ·Phase: PHASE2
-
SMART Project in Preventing Skin Cancer
NCT03177057 ·Status: COMPLETED ·Phase: NA
-
Talimogene Laherparepvec and Pembrolizumab in Treating Patients With Stage III-IV Melanoma
NCT02965716 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Tailored Internet Intervention to Reduce Skin Cancer Risk Behaviors Among Young Adults
NCT02147080 ·Status: COMPLETED ·Phase: NA
-
Bleomycin With or Without Electroporation Therapy in Treating Patients With Stage III or Stage IV Melanoma
NCT00006035 ·Status: UNKNOWN ·Phase: PHASE1
-
A Phase II Trial of PD-L1 Therapy Combined With Anti-VEGF Therapy in Unresectable or Metastatic Melanoma
NCT04356729 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma
NCT01245062 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating Engagement Patterns and Participation Trends Among Liposarcoma Patients
NCT06039046 ·Status: NOT_YET_RECRUITING